Evidence map›Paper›PMID 39857589›Full record

ArticleBiomedicines2024

Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers.

Andrea Rodríguez-Lopez, María Martínez-Sendino, Rocío Prieto-Pérez, Paula Soria-Chacartegui, Eva González-Iglesias, Mario Aparicio-Domínguez, Sonsoles Berenguer-Ruiz, Esteban Daudén, Francisco Abad-Santos

Abstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Genetic Association Study ofLife (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrea Rodríguez-LopezClinical Pharmacology Department, Hospital Universitario de La Princesa, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), 28006 Madrid, Spain.
María Martínez-SendinoClinical Pharmacology Department, Hospital Universitario de La Princesa, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), 28006 Madrid, Spain.
Rocío Prieto-PérezClinical Pharmacology Department, Hospital Universitario La Paz, Department of Pharmacology and Therapeutics, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), IdiPAZ, 28046 Madrid, Spain.ORCID 0000-0002-5055-8817
Paula Soria-ChacarteguiClinical Pharmacology Department, Hospital Universitario de La Princesa, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), 28006 Madrid, Spain.
Eva González-IglesiasClinical Pharmacology Department, Hospital Universitario de La Princesa, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), 28006 Madrid, Spain.ORCID 0000-0003-4875-6141
Mario Aparicio-DomínguezDermatology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa (IP), 28006 Madrid, Spain.
Sonsoles Berenguer-RuizDermatology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa (IP), 28006 Madrid, Spain.
Esteban DaudénDermatology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa (IP), 28006 Madrid, Spain.
Francisco Abad-SantosClinical Pharmacology Department, Hospital Universitario de La Princesa, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), 28006 Madrid, Spain.ORCID 0000-0002-6519-8885

Funding

Acción Estratégica en Salud 2017-2020, ISCIII ICI20/00131Comunidad de Madrid PIPF-2022/SAL-GL-25946Universidad Autónoma de Madrid FPI UAM-2021
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biologic therapiesloss of efficacypersistencepharmacogenetic biomarkerspsoriasis

Identifiers

PMID39857589
PMCPMC11762171

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.